Europos Sąjunga - slovėnų - EMA (European Medicines Agency)

aimmune therapeutics ireland limited - defatted powder of arachis hypogaea l., semen (peanuts) - peanut hypersensitivity - allergens - palforzia is indicated for the treatment of patients aged 4 to 17 years with a confirmed diagnosis of peanut allergy. palforzia may be continued in patients 18 years of age and older. palforzia should be used in conjunction with a peanut-avoidant diet.

Europos Sąjunga - slovėnų - EMA (European Medicines Agency)

bial portela & companhia s.a. - opikapon - parkinsonova bolezen - anti-parkinsonska zdravila - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.

Europos Sąjunga - slovėnų - EMA (European Medicines Agency)

yes pharmaceutical development services gmbh - doksorubicinijev klorid - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antineoplastična sredstva - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).

Europos Sąjunga - slovėnų - EMA (European Medicines Agency)

marinus pharmaceuticals emerald limited - ganaxolone - epileptic syndromes; spasms, infantile - drugi antiepileptics - ztalmy is indicated for the adjunctive treatment of epileptic seizures associated with cyclin-dependent kinase-like 5 (cdkl5) deficiency disorder (cdd) in patients 2 to 17 years of age. ztalmy may be continued in patients 18 years of age and older.

Slovėnija - slovėnų - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

stallergenes - alergenski izvlečki - suspenzija za injiciranje - alergenski izvlečki 10 ir / 1 ml - razni alergenski ekstrakti

Slovėnija - slovėnų - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

stallergenes - alergenski izvlečki - raztopina za kožni vbodni test - alergenski izvlečki 100 ir / 1 ml - alergijski testi

Slovėnija - slovėnų - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

stallergenes - alergenski izvlečki - suspenzija za injiciranje - alergenski izvlečki 10 ir / 1 ml - razni alergenski ekstrakti

Slovėnija - slovėnų - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

gsk d.o.o., ljubljana - amoksicilin; klavulanska kislina - prašek za peroralno suspenzijo - amoksicilin 80 mg / 1 ml  klavulanska kislina11,4 mg / 1 ml; klavulanska kislina 11,4 mg / 1 ml - amoksicilin in zaviralec laktamaz beta